Tag Archives: DIA

DIA: Social Media Guidelines are DDMAC’s "Highest Priority"

Tom Abrams, director of FDA’s Division (soon to be Office) of Drug Marketing, Advertising & Communications (DDMAC), said that publishing social media guidelines for industry is the division’s “highest priority,” and that the document will be “published as soon as it’s vetted.”
Posted in Advertising, E-Media, FDA, Marketing, Meetings, patient education, Regulatory, social media, Strategy, Technology | Also tagged , | 1 Comment

DIA: Does Six Sigma Stifle R&D Innovation?

Can the management style known as Six Sigma help improve the probability of a drug’s commercial success, or do its black-belted acolytes punch holes in the creative process needed for innovative R&D discovery?
Posted in IP, leadership, R&D, Strategy | Also tagged , , | 4 Comments

Pharma and Cloud Computing: Are We There Yet?

In the past few years, Microsoft has been working hard to create clinical trial platforms for the pharmaceutical industry. This year, the Redmond, WA-based behemoth has moved full-speed ahead with its virtual-server system, dubbed Azure. Microsoft is not only working on hosted applications, instead the company has established a massive online server or “cloud” that […]
Posted in Technology | Also tagged , , , | 1 Comment

Industry and FDA Brace for Change

While the convention floor of the 46th annual meeting of the Drug Information Association bustled with the usual vendors touting the latest and greatest clinical trial technology, the panels (particularly those that featured FDA members) had a remarkably somber tone. The main refrain was: “Things are going to change and everyone must step up or […]
Posted in Regulatory, Strategy | Also tagged , , , , , | 1 Comment

Hamburg Delivers DIA Keynote

FDA Commissioner Margaret Hamburg delivered this year’s keynote speech in front of a packed room of pharma and bioscience personnel at the 46th annual meeting of the Drug Information Association, which opened Monday morning. Hamburg started her speech by explaining how her earliest goal as FDA chief was to build the field of regulatory science—an […]
Posted in Events, FDA | Also tagged , , | 2 Comments
  • Categories

  • Meta